NSE · SUDEEPPHRM

Sudeep Pharma Limited

Sector: Chemicals · ISIN: INE0QPI01025

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#508

of 5,072 stocks

▲ 51W

Peak #508 · 27 Sep 2026

Sudeep Pharma Limited is a midcap company in the Chemicals space and carries a steep earnings multiple that prices in strong future growth, is growing revenue rapidly, and remains firmly promoter-controlled, with promoters holding 76%. Ownership as of Jun 2026.

Market Cap

13,157.43 Cr

P/E Ratio

75.15

P/B Ratio

14.65

ROE

19.41%

ROCE

24.22%

Dividend Yield

0.13%

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	158.27 Cr	182.34 Cr	172.34 Cr	162.67 Cr
Net Profit	40.59 Cr	48.54 Cr	47.70 Cr	46.78 Cr
EPS	3.59	4.38	4.29	4.20
Operating Profit	56.36 Cr	65.14 Cr	62.95 Cr	61.82 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

76.15%

Public

23.85%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

₹981.99

Cr total

Schemes

Fund Houses

₹981.99 Cr

Total Exposure

SBI Mutual Fund₹408.72 Cr (41.6%)

Axis Mutual Fund₹246.94 Cr (25.1%)

HDFC Mutual Fund₹114.86 Cr (11.7%)

Edelweiss Mutual Fund₹47.47 Cr (4.8%)

WhiteOak Capital Mutual Fund₹45.30 Cr (4.6%)

Others₹118.71 Cr (12.1%)

Scheme	Fund House	Value (Cr)	%

All MF holders by market value as of 01 Aug 2026.

Recent corporate actions

Ex-Date	Type	Details
23 Jul 2026	Dividend	Dividend - Rs 1.50 Per Share

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs